UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $385.30 and last traded at $383.2390, with a volume of 412263 shares traded. The stock had previously closed at $384.44.
UnitedHealth Group News Roundup
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UNH continues to draw bullish attention after its Q1 earnings beat, with articles highlighting strong margin improvement, a double-beat quarter, and renewed confidence in the company’s long-term outlook. UnitedHealth: Beaten Down, Not Broken
- Positive Sentiment: Analysts remain constructive on UnitedHealth Group, with JPMorgan raising its price target to $420 and reiterating an Overweight rating, reinforcing expectations that the stock can keep outperforming. Here’s What Analysts Are Saying About UnitedHealth Group (UNH)
- Positive Sentiment: Recent reports note that UNH has surged sharply since its earnings release and hit a new 52-week high, suggesting momentum traders and growth investors are still bidding the shares higher. UnitedHealth Stock (UNH) Hits a New 52-Week High Today – Is It Too Late to Buy?
- Neutral Sentiment: Several recent pieces simply highlight that UNH is heavily followed, widely discussed, and being screened as a momentum or blue-chip name, which may keep attention on the stock but does not add new fundamental information. Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
- Neutral Sentiment: Media coverage is also debating whether the stock is still a buy after its recent rally, reflecting mixed valuation concerns rather than a clear new catalyst. Is UnitedHealth Group a Buy, Sell, or Hold in 2026?
- Negative Sentiment: One article argues investors should “forget UnitedHealth” in favor of other names, which could slightly pressure sentiment by suggesting the stock may have less upside than alternatives after its strong rebound. Forget UnitedHealth: Two Stocks To Buy Now
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the stock. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $389.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Robert W. Baird increased their price target on UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a report on Wednesday, April 22nd. Morgan Stanley boosted their price objective on UnitedHealth Group from $375.00 to $395.00 and gave the company an “overweight” rating in a report on Wednesday, April 22nd. Finally, TD Cowen increased their target price on UnitedHealth Group from $311.00 to $337.00 and gave the stock a “hold” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $378.88.
UnitedHealth Group Stock Down 0.6%
The stock has a market cap of $362.20 billion, a P/E ratio of 30.12, a P/E/G ratio of 1.71 and a beta of 0.64. The company’s 50 day moving average price is $312.58 and its two-hundred day moving average price is $317.75. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The business had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the company posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 2.2%. UnitedHealth Group’s dividend payout ratio (DPR) is 66.77%.
Insider Activity at UnitedHealth Group
In other news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.28% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Sarver Vrooman Wealth Advisors purchased a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Beacon Financial Strategies CORP bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $26,000. Anfield Capital Management LLC grew its position in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC purchased a new position in UnitedHealth Group in the fourth quarter worth $27,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
- Five stocks we like better than UnitedHealth Group
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
